Match tier Listed
Presence Current · Arkansas
Last published 2022
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Catheryn D. Wilson

Researcher

Faculty Researcher

7 h-index 11 pubs 221 cited

  • Animals
  • Cannabinoids
  • Male
  • Receptor, Cannabinoid, CB1
  • Mice
  • Humans
  • Cannabinoid Receptor Agonists
  • Rimonabant
  • Substance-Related Disorders
  • Indoles
  • Naphthalenes
  • Dose-Response Relationship, Drug
  • Indazoles
  • Valine
  • Illicit Drugs

Biography and Research Information

OverviewAI-generated summary

Catheryn D. Wilson studies the effects of synthetic cannabinoid receptor agonists in mice, focusing on tolerance, dependence, and withdrawal. Her research investigates the potential for convulsive effects from these substances, examining whether specific synthetic cannabinoids elicit electroencephalographic (EEG) seizures in male mice. Wilson's work contributes to understanding the pharmacological profiles and potential toxicities of abused synthetic cannabinoids. She has published 11 papers with 220 citations and an h-index of 7. Her key collaborators include William E. Fantegrossi and Fang Zheng, both from the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications.

Metrics

  • h-index: 7
  • Publications: 11
  • Citations: 221

Selected Publications

  • Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice (2022)
    Psychopharmacology 4 citations DOI OpenAlex
  • Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal (2022)
    Drug and Alcohol Dependence 6 citations DOI OpenAlex
  • In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome (2019)
    Journal of Pharmacology and Experimental Therapeutics 24 citations DOI OpenAlex
  • <i>In vitro</i> and <i>In vivo</i> Effects of Phase 1 Hydroxylated Metabolites of the Synthetic Cannabinoid AB‐PINACA [(S)‐N‐(1‐amino‐3‐methyl‐1‐oxobutan‐2‐yl)‐1‐pentyl‐1H‐indazole‐3‐carboxamide] (2018)
    The FASEB Journal DOI OpenAlex
  • 2421 Development and validation of a translational rat model of neonatal abstinence syndrome (2018)
    Journal of Clinical and Translational Science DOI OpenAlex
  • Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice (2018)
    Journal of Pharmacology and Experimental Therapeutics 25 citations DOI OpenAlex
  • Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC (2018)
    Frontiers in Pharmacology 21 citations DOI OpenAlex
  • Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice (2018)
    Drug and Alcohol Dependence 7 citations DOI OpenAlex
  • Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems (2018)
    Drug Metabolism Reviews 72 citations DOI OpenAlex
  • The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice (2017)
    British Journal of Pharmacology 21 citations DOI OpenAlex
  • Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development (2017)
    Pharmacological Research 41 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

3 Collaborators 2 Institutions 1 Country

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics